Literature DB >> 33573218

Broad-Spectrum Antibiotics Deplete Bone Marrow Regulatory T Cells.

Hyojeong Han1, Hannah Yan2,3, Katherine Y King2,3.   

Abstract

Bone marrow suppression, including neutropenia, is a major adverse effect of prolonged antibiotic use that impairs the clinical care and outcomes of patients with serious infections. The mechanisms underlying antibiotic-mediated bone marrow suppression remain poorly understood, with initial evidence indicating that depletion of the intestinal microbiota is an important factor. Based on our earlier studies of blood and bone marrow changes in a mouse model of prolonged antibiotic administration, we studied whether changes in megakaryocytes or regulatory T cells (Tregs), two cell types that are critical in the maintenance of hematopoietic stem cells, contribute to antibiotic-mediated bone marrow suppression. Despite increased platelet numbers, megakaryocytes were unchanged in the bone marrow of antibiotic-treated mice; however, Tregs were found to be significantly depleted. Exogenous addition of Tregs was insufficient to rescue the function of bone marrow from antibiotic-treated mice in both colony formation and transplantation assays. These findings indicate that the intestinal microbiota support normal Treg development to protect healthy hematopoiesis, but that the restoration of Tregs alone is insufficient to restore normal bone marrow function.

Entities:  

Keywords:  T regulatory cells; antibiotics; bone marrow suppression; hematopoietic stem cell

Year:  2021        PMID: 33573218      PMCID: PMC7911786          DOI: 10.3390/cells10020277

Source DB:  PubMed          Journal:  Cells        ISSN: 2073-4409            Impact factor:   6.600


  17 in total

Review 1.  Bone-marrow haematopoietic-stem-cell niches.

Authors:  Anne Wilson; Andreas Trumpp
Journal:  Nat Rev Immunol       Date:  2006-02       Impact factor: 53.106

2.  Increased apoptosis and peripheral blood mononuclear cell suppression of bone marrow mesenchymal stem cells in severe aplastic anemia.

Authors:  Yu-Hua Chao; Chiao-Wen Lin; Hui-Hsien Pan; Shun-Fa Yang; Te-Fu Weng; Ching-Tien Peng; Kang-Hsi Wu
Journal:  Pediatr Blood Cancer       Date:  2018-06-05       Impact factor: 3.167

3.  Intrinsic impairment of CD4(+)CD25(+) regulatory T cells in acquired aplastic anemia.

Authors:  Jun Shi; Meili Ge; Shihong Lu; Xingxin Li; Yingqi Shao; Jinbo Huang; Zhendong Huang; Jing Zhang; Neng Nie; Yizhou Zheng
Journal:  Blood       Date:  2012-07-13       Impact factor: 22.113

4.  Antibiotics impair murine hematopoiesis by depleting the intestinal microbiota.

Authors:  Kamilla S Josefsdottir; Megan T Baldridge; Claudine S Kadmon; Katherine Y King
Journal:  Blood       Date:  2016-11-22       Impact factor: 22.113

5.  Adverse effects of outpatient parenteral antibiotic therapy.

Authors:  M L Hoffman-Terry; H S Fraimow; T R Fox; B G Swift; J E Wolf
Journal:  Am J Med       Date:  1999-01       Impact factor: 4.965

Review 6.  Systematic review: agranulocytosis induced by nonchemotherapy drugs.

Authors:  Frank Andersohn; Christine Konzen; Edeltraut Garbe
Journal:  Ann Intern Med       Date:  2007-05-01       Impact factor: 25.391

7.  Safety of Outpatient Parenteral Antimicrobial Therapy in Children.

Authors:  Priyanka Fernandes; Carly Milliren; Helen M Mahoney-West; Laura Schwartz; Catherine S Lachenauer; Mari M Nakamura
Journal:  Pediatr Infect Dis J       Date:  2018-02       Impact factor: 2.129

8.  Megakaryocytes regulate hematopoietic stem cell quiescence through CXCL4 secretion.

Authors:  Ingmar Bruns; Daniel Lucas; Sandra Pinho; Jalal Ahmed; Michele P Lambert; Yuya Kunisaki; Christoph Scheiermann; Lauren Schiff; Mortimer Poncz; Aviv Bergman; Paul S Frenette
Journal:  Nat Med       Date:  2014-10-19       Impact factor: 53.440

9.  Regulatory T cells inhibit CD34+ cell differentiation into NK cells by blocking their proliferation.

Authors:  Isabela Pedroza-Pacheco; Divya Shah; Anna Domogala; Martha Luevano; Michael Blundell; Nicola Jackson; Adrian Thrasher; Alejandro Madrigal; Aurore Saudemont
Journal:  Sci Rep       Date:  2016-02-26       Impact factor: 4.379

Review 10.  Microbiome Dependent Regulation of Tregs and Th17 Cells in Mucosa.

Authors:  Pushpa Pandiyan; Natarajan Bhaskaran; Mangge Zou; Elizabeth Schneider; Sangeetha Jayaraman; Jochen Huehn
Journal:  Front Immunol       Date:  2019-03-08       Impact factor: 7.561

View more
  6 in total

Review 1.  Microbial Sensing by Hematopoietic Stem and Progenitor Cells.

Authors:  Pijus K Barman; Helen S Goodridge
Journal:  Stem Cells       Date:  2022-03-03       Impact factor: 5.845

2.  Antimicrobial-induced oral dysbiosis exacerbates naturally occurring alveolar bone loss.

Authors:  Brooks A Swanson; Matthew D Carson; Jessica D Hathaway-Schrader; Amy J Warner; Joy E Kirkpatrick; Alexa Corker; Alexander V Alekseyenko; Caroline Westwater; J Ignacio Aguirre; Chad M Novince
Journal:  FASEB J       Date:  2021-11       Impact factor: 5.191

3.  Code Red in the Supply Center: The Impact of Immune Activation on Hematopoiesis.

Authors:  Katherine C MacNamara; Martijn A Nolte
Journal:  Cells       Date:  2022-05-09       Impact factor: 6.600

4.  The bacterial microbiota regulates normal hematopoiesis via metabolite-induced type 1 interferon signaling.

Authors:  Hannah Yan; Forrest C Walker; Arushana Ali; Hyojeong Han; Lin Tan; Lucas Veillon; Philip L Lorenzi; Megan T Baldridge; Katherine Y King
Journal:  Blood Adv       Date:  2022-03-22

5.  Breaking down antibiotic resistance in methicillin-resistant Staphylococcus aureus: Combining antimicrobial photodynamic and antibiotic treatments.

Authors:  Jace A Willis; Vsevolod Cheburkanov; Shaorong Chen; Jennifer M Soares; Giulia Kassab; Kate C Blanco; Vanderlei S Bagnato; Paul de Figueiredo; Vladislav V Yakovlev
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-29       Impact factor: 12.779

6.  Gentamicin promoted the production of CD4+CD25+ Tregs via the STAT5 signaling pathway in mice sepsis.

Authors:  Jinfeng Li; Fengdan Xu; Song Li; Mingyu Xie; Ning Li
Journal:  BMC Immunol       Date:  2022-09-26       Impact factor: 3.594

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.